Category: CBDs
-
1933 Industries (TGIF.C) is getting bigger, bolder, more badass
On January 22, 2020 1933 Industries (TGIF.C) gave the market an update on its bulk hemp processing facility in Las Vegas, USA. The facility will be capable of producing isolated cannabinoids such as CBD, CBG, CBC and CBN, as well as full spectrum and broad-spectrum oils without THC. The proprietary extraction system will reduce industry-standard…
-
Fundamental Hype: Vivo Cannabis (VIVO.V) doubles stock price in no time flat: But why?
Way way waaaay back, when Equity.Guru was a young pup and the cannabis industry was still being built on fumes of promise, Vivo Cannabis (VIVO.V) – formerly AbCann – was an industry darling. For a hot minute, anyway. The reasons why Vivo fell off the table and not only grew out of favour, but almost…
-
Cannabis 2.0 needs a hero… is it (LOL) no really, is it… Namaste (N.C)?
If Equity.Guru had a wall of shame in our fine sea foam blue offices, Namaste would be on it, along with Wayland Group (WAYL.C), CEN Biotech (FITX), MedMen (MMEN.C), St Jean Carbon (SJL.V), Imagination Park (IP.C), Affinor Growers (AFI.C), Abattis Bioceuticals (ATT.C), CUV Ventures/RevoluGroup (REVO.V), and a host of others that we went to war…
-
Vext Science (VEXT.C) cannabis chart defies gravity
“The core business, which is derived from an Arizona licensed vertically integrated model, generated USD $13 million in revenues during the first two quarters of 2019,” confirmed Equity Guru’s Sam Bourgi last October. Ironically, VEXT is a healthy cannabis business, and investors are quickly gaining confidence in it.
-
2019 weed wrap: The end of the cannabis cycle of cannabis cycles
Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they’re at the predator’s table because they’re the…
-
![Yield Growth (BOSS.C) looks into 2020 crystal ball and sees a shroom boom]()
Yield Growth (BOSS.C) looks into 2020 crystal ball and sees a shroom boom
Through its subsidiaries, Yield Growth has over 200 proprietary beauty, wellness, edibles and beverage formulas for commercialization. It has filed 13 patents to protect its extraction method and IP. Yield Growth earns revenue through multiple streams including licensing, services and product sales.
-
![A tale of two factories: World Class Extractions (PUMP.C) and Naturally Splendid (NSP.V) might surprise you]()
A tale of two factories: World Class Extractions (PUMP.C) and Naturally Splendid (NSP.V) might surprise you
Over the last month I’ve left the happy confines of Casa Guru a few times and headed out to the suburbs to catch up with old friends. Both trips turned out to be surprising and interesting experiences with a similar message; “The market doesn’t see us, but we’re doing the work and quietly confident we’re…
-
![Chemesis (CSI.C) Q1, 2020 cannabis revenue up 279% – official “survivor” status?]()
Chemesis (CSI.C) Q1, 2020 cannabis revenue up 279% – official “survivor” status?
On January 10, 2018 (almost two years ago), the Canadian Marijuana Index peaked just north of a 1,000. At that time, the valuation of almost every cannabis company looked rich. Today, the Canadian Marijuana Index is at 212 (down 80%). These days, the pom-poms are locked firmly in a drawer, but it is worth pointing…
-
![SOL Global (SOL.C) revs up in Florida, financials dragged down by Verano investment]()
SOL Global (SOL.C) revs up in Florida, financials dragged down by Verano investment
On December 2, 2019 Sol Global (SOL.C) released its Q2, financial results for the three and six-month period ended September 30, 2019. SOL Global invests in cannabis related companies in legal U.S. states, hemp and CBD marketplaces and the emerging European cannabis and hemp territories. Its business activities encompass cultivation, distribution, retail – and an…
-
Yeah we lost money, what’s it to you? 1933 Industries (TGIF.C) takes the transparent route and we love it
Regular readers will know I’ve been a little quiet of late on the cannabis space, which is by design. If I’m not going in full welly on a given sector or company, I’m certainly not going to suggest you should, and quite frankly the cannabis business was overdue for a reckoning, as I stated back…
